Delivery Order SPE2DB20D1100-SPE2DB24FD9F5

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,433.25 firm-fixed-price contract is for the delivery of UBRELVY 50 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. This contract is not set aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The fixed-price contract has a ceiling value of $23,940.75 and a period of performance through June 5, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The order has a ceiling value of $8,337.85 and a completion date of July 30, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,747.48, is for the supply of UBRELVY 50 MG TABLET UD 10S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 2, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,375.92, is for the delivery of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,451.70 contract is for the supply of UBRELVY 100MG TAB 10S, a prescription medication. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of UBRELVY 100 MG TABLET UD 10S, a prescription pharmaceutical product. The order has a ceiling value of $8,001.36 and a completion date of September 25, 2024. The contract is a Firm Fixed Price type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of UBRELVY 100 MG TABLET UD 10S. The contract has a ceiling value of $3,256.08 and a completion date of May 20, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug UBRELVY 100 MG TABLET UD 10S. The $3,266.87 firm-fixed-price contract has a completion date of May 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00, which allows the company to provide a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,146.60 and a period of performance through May 16, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD9F5
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $10,425.84, is for the supply of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has a period of performance through September 20, 2024, and is a firm fixed-price delivery order. No set-aside designation was used. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a wide range of essential medical commodities.

Generated 12/19/24, 9:17 AM